Sexually transmitted diseases (STDs) continue to be a major public health challenge in the U.S. An estimated 19 million new infections cost an estimated at $14.7 billion annually. The upward trend in STD infection rates and in prevention and treatment costs continues because, for years, public health and STD prevention efforts have been woefully underfunded while costs for new tests, treatments and vaccine technologies have soared.
To examine how states are funding their own STD prevention efforts, ASHA measured state funding in FY2007 and FY 2009. We also collected expenditure and policy data for both years.
A full report of this project is available for download. The report provides a comprehensive overview of the project, including an explantion of project methods, measures, a breakdown of categories of state expenditures, and a detailed analysis of the state policy climate for STD prevention
ASHA would like to extend a special note of thanks to the National Coalition of STD Directors (NCSD) , the Association of Public Health Laboratories (APHL), the Association of Immunization Managers (AIM) , and the National Alliance of State and Territorial AIDS Directors (NASTAD) . These four membership organizations were invaluable in endorsing and disseminating the data collection tools among their constituents.
If you have questions or comments about this project, or suggestions about data collection efforts in the future, please e-mail us. We would also be interested to learn how this data were used.